Microfluidics: Concept to Market
Bay Area Microfluidics Network hosted this event on December 2nd, 6:00 – 9:00 pm, at IndieBio in San Francisco.
This event was generously sponsored by:
Time: 6:00 – 9:00pm
- Street parking is very limited
- Powell Street BART is a short walk – we highly encourage taking public transit
- Registration, networking and buffet
- Keynote speaker 1: Vikram Chaudhery, Principal, Genoa Ventures
- Keynote speaker 2: Camelia Rusu, Sr. Director – Emerging Business, Lam Research
- Discussion with speakers: (Moderator) Dr. Don Arnold, CEO, Veristad
- After-event social
Dr. Vikram Chaudhery
Vikram Chaudhery, Ph.D. is a Principal at Genoa Ventures with experiences as a business executive, life sciences investor, management consultant and entrepreneur.
As a business leader with an academic background in genomics and proteomics, Vikram has spent the last decade leading and working with organizations in the life sciences industry. Vikram launched his business career with iconic strategy consulting firm McKinsey & Co. where he combined his creative thinking, business acumen and technical proficiency to collaborate with pharmaceutical, diagnostics, medical device and biotechnology companies to bolster operational efficiencies and drive new business development. At McKinsey, Vikram led the Life Sciences Tools practice and was an expert technical contributor to the Personalized Medicine practice.
Prior to joining Genoa, Vikram served as Head of Life Sciences at Lam Research where he led overall strategy, partnership/business development and venture investment functions for life sciences, focusing on next generation ‘omics technologies.
Vikram holds a Ph.D. in electrical engineering and biological systems engineering from the University of Illinois where he previously earned a Master of Science in electrical engineering, biological systems engineering and biosensor fabrication. During this time, he has co-authored 25 peer-reviewed scientific publications including 14 peer-reviewed articles and 11 presentations at life science industry conferences.
Dr. Camelia Rusu
Camelia Rusu is a Senior Director with Lam Research Corporation. In her current role she is leading the nanoString- Lam strategic collaboration to develop the Next Generation Sequencing platform. She manages a multi-disciplinary engineering team (optics, process, microfluidics) to improve flow cell efficiency, to screen and select HVM (high volume manufacture) suppliers. Camelia joined Lam Research after graduate school and has been with the company since 2000. She started as a process engineer and consistently advanced to her current position while holding various leadership positions: process etch manager, head of the 3DIC team, head of memory Dielectric Etch Product Group for Micron Global Account and Intel memory, and most recently leading the Emerging Business Engineering team. Over the years she had the opportunity to develop multiple technologies for semiconductor equipment, to implement and transfer them at worldwide customer sites, and to grow exceptional teams. Camelia received a Ph.D. in Physical Chemistry from University of Pittsburgh, Pennsylvania, USA.